Determination of famotidine in human plasma by high performance liquid chromatography with column switching

While functional magnetic resonance imaging (fMRI) is now used widely for demonstrating neural activity-related signals associated with perceptual, motor, and cognitive processes in humans, to date this technique has not been developed for use with nonhuman primates. fMRI in monkeys offers a potentially valuable experimental approach for investigating brain function, which will complement and aid existing techniques such as electrophysiology and the behavioral analysis of the effects of brain lesions. There are, however, a number of significant technical challenges involved in using fMRI with monkeys. Here, we describe the procedures by which we have overcome these challenges to carry out successful fMRI experiments in an alert monkey, and we present the first evidence of activity-related fMRI signals from monkey cerebral cortex.     

Determination of cefixime in human plasma and urine using high performance liquid chromatography column switching technique

A double column and double pump HPLC switching system is described for the analysis of cefixime in human plasma and urine. The system used muBondapak C18 short pretreatment column for on-line sample clean-up and a Hitachi GEL 3056 (ODS) analytical column for separation. A mixed solution of 0.01 mol/L H3PO4-0.1 mol/L KH2PO4-H2O (20:1:79) was used as the pretreatment mobile phase and CH2CH-0.01 mol/L H3PO4-0.1 mol/L KH2PO4-H2O (13:20:1:66) was used as analytical mobile phase. The compound in plasma and urine is detected by ultraviolet absorption at 286 nm and 314 nm, respectively. The absolute recoveries of the method in plasma and urine were 99.1% and 98.6% respectively. The relative standard deviations of the method are 0.70-3.82% and 0.80-3.73% in plasma, 1.53-3.08% and 1.31-2.67% in urine between days and day-to-day. Linear calibration curve for cefixime was measured over the range of 0.1-3.2 micrograms/ml in plasma and 1.0-32.0 micrograms/ml in urine, and the correlation coefficients were all 0.9999. The detection limit was 0.05 micrograms/ml in plasma and 0.2 micrograms/ml in urine. The plasma and urine samples were diluted with water and injected directly onto the HPLC system. The operation is simple and the relative sensitivity is markedly increased because of higher recoveries and larger loading capacity of the sample.     

索氏抽提-柱层析分离-高效液相色谱法测定煤沥青中多环芳烃

以甲苯为溶剂对煤沥青进行索氏抽提,抽提液经过有机滤膜过滤,过滤后的抽提液用二氯甲烷溶解,将样品溶液用硅胶柱分离,然后用体积比为1∶1的石油醚与甲苯混合液以5.0mL/min的流量进行淋洗,将淋洗液旋干后用乙腈定容至10mL,利用ZORBAX Eclipse PAH柱以不同体积比的乙腈-水体系为流动相对样品溶液进行梯度洗脱,建立了煤沥青中16种多环芳烃(PAHs)的高效液相色谱分离检测方法。结果表明,16种PAHs的线性范围为0.50~20mg/L,相关系数(r)不小于0.999,检出限为0.04~0.33μg/L,按照实验方法对湘钢煤沥青实际样品中16种PAHs进行测定,测得结果的相对标准偏差(RSD,n=6)为0.20%~3.5%,回收率为97%~109%。采用实验方法分别测定湘钢、涟钢两种不同煤沥青中16种PAHs的含量,测得结果与湘钢、涟钢两公司提供的推荐值基本一致。结果表明,每1kg湘钢煤沥青中16种致癌性PAHs质量为107.9g,即质量分数为10.79%;每1kg涟钢煤沥青中16种致癌性PAHs质量为104.1g,即质量分数为10.41%;其中苯并[a]芘分别为11.86g/kg和13.82g/kg,即质量分数为1.186%和1.382%。     

Determination of nimesulide and hydroxynimesulide in human plasma by high performance liquid chromatography

Two specific methods for the simultaneous determination of nimesulide, a non steroidal anti-inflammatory drug, and its hydroxylated metabolite in human plasma are described. Adopting a high performance liquid chromatographic (HPLC) system with UV detection (230 nm), the compounds, extracted from plasma in acidic medium, were separated on ODS columns under gradient conditions, using a phosphate buffer solution and methanol as mobile phase. For each method column length, gradient rate and composition were appropriately selected. The limit of quantitation was 25 ng/mL for both compounds. The two methods were validated by intra day assays at three concentration levels and applied in kinetic studies in healthy volunteers, during which inter-day assays were carried out confirming their feasibility.     

Determination of free bile acids in pharmaceuticals by thin layer chromatography and high performance liquid chromatography

High-performance liquid chromatography with evaporative light scattering detection (HPLC-ELSD) and thin layer chromatography with flame ionization detection (TLC-FID) have been applied to the separation of five main free bile acids present in humans: cholic (CA), chenodeoxycholic (CDCA), deoxycholic (DCA), lithocholic (LCA) and ursodeoxycholic (UDCA) acid. HPLC separation was performed on Biospher Si 100 column using a mixture of n-heptane, isopropanol, ethylacetate, methanol and glacial acetic acid as a mobile phase. All the compounds were separated in less than 12 minutes by using a gradient elution mode. TLC-FID separation was performed on S-II Chromarods with a mixture of isooctane, ethylacetate and glacial acetic acid as a mobile phase. HPLC-ELSD method was applied to the determination of CDCA and UDCA in pharmaceuticals and their purity control when LCA, DCA and CA were considered as impurities.     

Determination of meropenem in serum by high-performance liquid chromatography with column switching

A rapid, accurate and sensitive liquid chromatographic assay with on-line solid-phase extraction for determination of meropenem in serum is described. Sample was directly injected onto the extraction column for sample clean-up and extraction. Thereafter, using an on-line column-switching system the drug was quantitatively transferred and separated on a C18 analytical column. Ultraviolet absorption at 298 nm was used for detection. The assay was linear from 1 to 100 micrograms/ml. Recovery was 98.5%. Based on a 20-microliters sample volume (serum- water, 1:1, v/v), detection limit was 0.1 microgram/ml. An application of the method to study the pharmacokinetics of meropenem is given.     

Determination of l-menthol in pharmaceutical products by high performance liquid chromatography with polarized photometric detection

PURPOSE: An immortalized human corneal epithelial cell line (HCE) was tested as a screening tool for prediction of topical ocular irritation/toxicity by pharmaceuticals METHODS: Effects of various drugs, excipients and cyclodextrins (CDs) on viability of HCE cells were evaluated using two in vitro cytotoxicity tests, 3-(4,5-dimethlthiazol-2-yl)-205-diphenyl tetrazolium bromide (MTT) dye reduction assay and propidium iodide assay. RESULTS: Mitochondrion-based MTT test was a more sensitive indicator of cytotoxicity than the plasma membrane-based propidium iodide test. The tests revealed following cytotoxic rankings for ophthalmic drugs: dipivefrin > timolol > pilocarpine approximately equal to dexamethasone; for excipients: benzalkonium chloride (BAC) > sodium edetate (NA2 EDTA)>polyvinyl alcohol (PVA) > methylparaben; and for CDs :alpha- CD > dimethyl beta-cyclodextrin (DM-beta-CD) > sulfobutyl ether beta-cyclodextrin ((SBE)7m-beta-CD approximately equal to hydroxypropyl-beta-cyclodextrin (HP-beta-CD) > lambda CD. In consideration of the in vivo clinical situation, the short exposure time (5 min) is more relevant even though toxic effects of some test substances were seen only after longer exposure time (30 and 60 min). CONCLUSIONS: Immortalized HCE cells are a promising tool for rapid cytotoxicity assays of ocular medications. The cell line is potentially useful in predicting the in vivo coreal toxicity of ocularly applied compounds.     

Quantitative analysis of ceramide molecular species by high performance liquid chromatography

BACKGROUND: Hepatocyte growth factor/scatter factor (HGF/SF) is a potent mitogen for various neoplastic cells, including neoplastic bronchial epithelia. METHODS: Immunoreactive hepatocyte growth factor/scatter factor (HGF/SF) was measured in extracts prepared from 129 nonsmall cell lung carcinoma (NSCLC) specimens, using an enzyme-linked immunosorbent assay. These specimens represented 5 cases of solitary/localized bronchioloalveolar cell carcinoma (BAC), 4 cases of diffuse/infiltrative BAC, 90 cases of non-BAC adenocarcinoma, 25 cases of squamous cell carcinoma, and 5 cases of large cell carcinoma. RESULTS: The mean concentration of immunoreactive HGF/SF was more than 19-fold higher in tissue extracts from diffuse-type BAG (265.0 +/- 110.2 ng/100 mg protein) than in those from solitary-type BAC (13.9 +/- 15.9, P < 0.005), non-BAC adenocarcinoma (13.8 +/- 14.9, P < 0.001), squamous cell carcinoma (13.2 +/- 14.4, P < 0.001), or large cell carcinoma (11.2 +/- 6.5, P < 0.005). When immunohistochemical staining for HGF/SF was performed, intense HGF/SF staining was uniformly observed in diffuse-type BAC tumor cells, but not in solitary-type BAC. CONCLUSIONS: Although BAC is included as a subtype of adenocarcinoma in the World Health Organization classification, diffuse-type BAC should be considered a distinct biologic entity, at least in terms of HGF/SF expression, from solitary-type BAC or non-BAC adenocarcinoma. In addition, the solitary and diffuse forms of BAC are known to be associated with different prognoses; for the latter, the prognosis is much poorer than for the former. The results of this study may at least partly explain this difference in prognosis.     

Biological monitoring of exposure to chlorpyrifos by high performance liquid chromatography

Sixteen patients with hypogonadotropic hypogonadism received gonadotropin replacement therapy. Two patients treated with HCG alone showed induction of spermatogenesis 2 and 12 months after the start of treatment. Three subjects receiving combination therapy showed sperm appearance 6-28 months after treatment. The patients showing sperm appearance, whose testicular volume was > or = 4 ml, showed a higher sperm count and impregnated their partners, although no relationship was found between pretreatment testicular volume and sperm appearance. The response to HCG test correlated with sperm appearance after gonadotropin therapy. Sperm appearance was not observed in any subject except for one who showed no response to luteinizing hormone-releasing hormone (LH-RH) test and none of the patients without response of FSH to LH-RH demonstrated any induction of spermatogenesis. In conclusion, the responses to LH-RH test and possibly to HCG test could predict the induction of spermatogenesis after gonadotropin replacement therapy, and a large testicular volume is associated with post-treatment fertility.     

Determination of hepatotoxic pyrrolizidine alkaloids by on-line high performance liquid chromatography mass spectrometry with an electrospray interface

The present study describes the determination of two different types of hepatotoxic pyrrolizidine alkaloids (PAs) and also distinguishing the hepatotoxic PAs from non-toxic ones by both in-source collision-induced dissociation high performance liquid chromatography mass spectrometry (CID-HPLC/MS) and HPLC/MS/MS (CID in the collision cell), using electrospray ionization. The mass spectra provided molecular ions and characteristic fragment ions, which could be used readily for a rapid identification of different types of PAs. Applications of both in-source CID-HPLC/MS and HPLC/MS/MS analytical methods were successful for the determination of PAs in blood samples obtained from rats dosed with PAs and in the PA-containing plant. The results demonstrated that the developed HPLC/MS methods with two different CID techniques provided a very simple and rapid analysis for an unequivocal diagnosis of PA poisoning and for definitive identification of PAs in plants or herbal medicines.     

高效液相色谱法测定湿法冶金LIX984N铜萃取剂中醛肟和酮肟

醛肟和酮肟的含量直接决定其羟肟类铜萃取剂(以下简称铜萃取剂)的萃取性能状况,因此建立简便可行的测定铜萃取剂中醛肟和酮肟含量的方法意义重大。实验在无醛肟和酮肟标准样品的前提下,选取LIX984N为原料,采用液相色谱仪以半制备方法制备了纯醛肟和酮肟,并以此为标准品,建立了测定湿法冶金LIX984N铜萃取剂产品中醛肟和酮肟的高效液相色谱(HPLC)分析方法。优化后的液相色谱仪操作条件如下:Chromatorex(迪玛)C18(300 mm×30 mm×10 μm)反相柱为半制备柱,ChromatorexC18(250 mm×4.6 mm×5 μm)反相柱为分析柱,甲醇为流动相,流动相流速为1.0 mL/min,柱温为室温,紫外检测器波长为254 nm。实验表明,醛肟和酮肟均在质量浓度为0.4 μg/mL～1.50 mg/mL范围内与其对应的色谱峰面积呈良好的线性关系,相关系数均大于0.998。醛肟和酮肟的方法检出限分别为0.12和0.15 μg/mL,测定下限分别为0.4和0.5 μg/mL。按照实验方法对LIX984N铜萃取剂样品中醛肟和酮肟进行测定,结果的相对标准偏差(RSD,n=5)均小于0.5%,加标回收率为94%～129%。     

超高效液相色谱法测定甲基磺酸锡电镀液中甲基磺酸

准确测定甲基磺酸锡电镀液中甲基磺酸的含量对镀锡板稳定生产和电镀液老化评价有着重要意义。采用BEH Amide色谱柱(3.0×150mm,1.7μm),以0.010mol/L乙酸铵乙腈溶液-0.010mol/L乙酸铵水溶液(体积比为80∶20)为流动相,控制流速为0.40mL/min,建立了超高效液相色谱法测定甲基磺酸锡电镀液中甲基磺酸含量的方法。干扰试验表明:甲基磺酸锡电镀液中其他共存组分对甲基磺酸的测定均没有干扰。在甲基磺酸质量浓度为1.00~10.00mL/L范围内,甲基磺酸质量浓度的对数与其峰面积的对数呈线性关系,线性相关系数为0.999 6。将实验方法应用于甲基磺酸锡电镀液实际样品中甲基磺酸的测定,测得结果的相对标准偏差(RSD,n=11)为0.79%~1.2%,加标回收率为99%~102%。按照甲基磺酸锡电镀液配方体系配制甲基磺酸锡电镀液合成样品,并采用实验方法进行测定,测定值与理论值相符。     

高效液相色谱法测定硫酸锌电解液中的α-亚硝基-β-萘酚、β-萘酚

采用反向高效液相色谱法测定硫酸锌电解液中的α-亚硝基-β-萘酚、β-萘酚。此法采用无水乙醇沉淀试样中的大部分硫酸锌,使用日本岛津液相色谱柱,以甲醇:水（磷酸二氢钾KH₂PO₄（0.05mol/L））为流动相,流速为1 mL/min,检测波长为280 nm。研究表明:含量在0.2 mg/L以上检测值与峰面积呈良好的线性关系,相关系数都为0.9998。本方法对α-亚硝基-β-萘酚和β-萘酚的检出限为0.2mg/L,α-亚硝基-β-萘酚的回收率为99.30%,β-萘酚的回收率为99.07%。该方法能够快速进行锌电解液中α-亚硝基-β-萘酚、β-萘酚的测定。     

A study on the stability of bronopol in bronopol lotion by ion-paired reversed-phase high performance liquid chromatography

Six patients with avulsion fractures of the metacarpophalangeal joints of the fingers are reported. Operation was performed in all cases. Judging from the operative findings, the radiological assessment of fragment shape is helpful in treatment. Surgery is recommended when the fragment is triangular or rectangular in shape because the fracture involves the articular surface. Conservative treatment is effective if the fragment is round because the articular surface of the joint is not involved in this type of fracture. The avulsed fragment often overlaps the metacarpal head and a collateral ligament injury is likely to be misdiagnosed. It is important to suspect this injury and assess the shape of the whole fragment for a good functional result.